Daily News header

Hormones: Still Pushed by Pharma; Still Dangerous

By

The medical press trumpeted again this month the shopworn pharma factoid that menopausal hormones may be good for you, not bad. This is at least the eighth time researchers have tried to resuscitate the therapy and its franchise profits since a government study linked it to cancer and heart disease in 2002.

The report stemmed from a poster Dr. Joseph Ragaz, clinical professor at the University of British Columbia, presented at the San Antonio Breast Cancer Symposium this month.

The evidence that estrogen can protect against breast cancer has "been largely ignored" news reports quote Dr. Joseph Ragaz saying.

sleepz

Estrogen was once thought "the culprit in the elevated breast cancer risk seen among women" in the government-funded Women's Health Initiative, says a Medpage article.

That study, funded by the National Heart, Lung and Blood Institute, was terminated in 2002 because the risks to women outweighed the benefits. Progestin with estrogen were linked to a 26 percent increase in breast cancer, 41 percent increase in strokes, 29 percent increase in heart attacks, 22 percent increase in cardiovascular disease and double the rate of blood clots.

Hormone therapy is also linked to lung, ovarian, breast and gall bladder cancer, melanoma and dementia in medical studies and journal articles. Over 5,000 women have brought suit over breast cancers they developed on the drugs.

But what Medpage does not mention is that progestin was added to estrogen because women taking estrogen alone developed endometrial cancer!

So many women developed endometrial cancer, the cancer rate actually dropped when they quit taking estrogen by itself, usually as the drug Premarin, in the 1980s.

Just like the breast cancer rate fell when women quit taking estrogen and progestin, usually as Prempro, in 2002.

Why are reports that a drug that causes endometrial cancer but may reduce breast cancer good news? Is the idea to switch cancers?

And why are Pfizer-linked researchers at major universities trying to bring back the lucrative franchise by testing cognitive and cardiovascular "benefits" in defiance of hormones' known heart and dementia side effects?

Does anyone need a second opinion?

Martha Rosenberg is a columnist and cartoonist, who writes about public health

  Please leave a comment here     If it does not display within 10 seconds, please refresh the page

Related Health News News

Ebola is here in the U.S. and will soon be in other countries outside of the African continent. Learn the real chances you could catch it.
Health and Diet Expert Dr. J Helps Hollywood With All Natural Methods, instead of often times deadly pharmaceutical drugs that have killed many stars.
Nurit Greenger writes about and event that empowers women to accept themselves as they are, no matter what size, weight, age, race or body shape they are.
There have been other Ebola cases treated in the U.S. but those were all medical workers who became infected while working in Africa. The new case was initially diagnosed Dallas, Texas.
World Heart Day, 29th September 2014
Incidentally 22nd Cochrane Colloquium on 'evidence-informed public health: challenges and opportunities' theme is being held in Hyderabad, India (21-26 September 2014) and will be followed by the 3rd Global Symposium on Health Systems Research on

 

NewsBlaze Writers Of The Month



Popular Stories This Month

newsletter logo

NewsBlaze
Copyright © 2004-2014 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site